AbbVie Inc. against EssilorLuxottica Société anonyme — live side-by-side technical comparison.
Prices as of 2026-10-07T20:00:03+00:00 UTC · updates daily
ABBV leads 5 of the 5 windows we measure — over 1 month ABBV is +5.8% and EL.PA -3.6%; over year to date ABBV is +18.8% and EL.PA -46.6%.
| ABBV | EL.PA | |
|---|---|---|
| Price | $271.36 | $144.20 |
| 1 day | +1.8%lead | -1.7% |
| 5 days | +3.7%lead | -0.3% |
| 1 month | +5.8%lead | -3.6% |
| 6 months | +31.5%lead | -28.1% |
| Year to date | +18.8%lead | -46.6% |
| 52-week position | 96% of range | 3% of range |
| 52-week range | $190.75–$274.94 | $138.30–$323.80 |
| vs 50-day average | above $258.33 | below $154.64 |
| vs 200-day average | above $232.18 | below $192.59 |
| RSI (14) | 67 | 58 |
| Next earnings | 2026-10-30 | 2026-02-11 |
ABBV trades at $271.36, above its 50-day average of $258.33, and above the 200-day at $232.18. It sits at 96% of its 52-week range ($190.75–$274.94); 14-day RSI is 67, in neutral territory; an average session moves it about 2.0%. For levels, the first level overhead is $275.00 (1.3% away) and the first support below is $267.94 (1.3% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
EL.PA trades at $144.20, below its 50-day average of $154.64, and below the 200-day at $192.59. It sits at 3% of its 52-week range ($138.30–$323.80); 14-day RSI is 58, in neutral territory; an average session moves it about 2.8%. For levels, the first level overhead is $150.00 (4.0% away) and the first support below is $139.00 (3.6% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
EL.PA is the more volatile of the two — an average session moves it 2.8% against 2.0% for ABBV, so an identical position size carries roughly 1.4× the daily risk.
The comparison turns on those levels: ABBV clearing $275.00 or losing $267.94; EL.PA clearing $150.00 or losing $139.00. Until one of them gives way, the relative reading above stands.